Annual review of basic research on lung transplantation worldwide in 2025
- VernacularTitle:2025年国内外肺移植基础研究年度盘点
- Author:
Jier MA
1
;
Kemeng SUN
1
;
Xiaohan JIN
1
;
Jiaqi LI
1
;
Xinyue ZHANG
1
;
Chama LOUJAINE
1
;
Junmin ZHU
1
;
Hengtao LIN
1
;
Xiangyun ZHENG
2
;
Junjie WANG
2
;
Zengwei YU
2
;
Yaling LIU
2
;
Haoji YAN
2
;
Dong TIAN
3
Author Information
- Publication Type:AcademicSummary
- Keywords: Lung transplantation; Infection; Rejection; Ischemia-reperfusion injury; Chronic lung allograft dysfunction; Donor lung protection
- From: Organ Transplantation 2026;17(4):582-593
- CountryChina
- Language:Chinese
- Abstract: Lung transplantation is a definitive treatment for end-stage lung disease and can significantly improve patient prognosis. However, postoperative complications such as infection, rejection, ischemia-reperfusion injury and chronic lung allograft dysfunction intertwine to form a complex pathological network, posing persistent challenges to long-term patient survival. In 2025, research teams worldwide have made systematic progress in the field of basic lung transplantation research. By integrating cutting-edge technologies including single-cell multi-omics, spatial transcriptomics and novel animal models, significant breakthroughs have been achieved in the evolutionary dynamics of drug-resistant infections, molecular mechanisms of immune regulation, programmed cell death, optimization of donor lung protection strategies and early warning of chronic lung allograft dysfunction. This article systematically reviews the representative advances in basic lung transplantation research worldwide in 2025, and deeply analyzes the implications of mechanistic breakthroughs for optimizing diagnosis and treatment strategies, aiming to anchor the direction for innovative breakthroughs and clinical translation in basic lung transplantation research.
